BridgeMD
New treatment option for Ankle Sprain
Official title NMES With PNF for Ankle Sprain Rehabilitation
ClinicalTrials.gov ID: NCT07190599
What this study is testing
- What it's testing
- Ankle sprains are one of the most common sports injuries. In some people, they can lead to chronic ankle problems that affect daily life and sports performance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30
You may be able to join if
- Aged 18-30 years
- Adults with a history of ankle sprain
You likely can't join if
- Participants with ankle fractures, dislocations, grade III ankle sprains, bony restrictions, swelling, neuropathy, or any other neuromuscular...
The study team makes the final eligibility decision.
Where it's taking place
- Kaohsiung City, No. 151, Jinxue Road, Daliao District, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kaohsiung City, No. 151, Jinxue Road, Daliao District, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.